title: Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
authors.affiliation: Department of Urology, General Hospital of Bolzano, Bolzano, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Lodde
authors.forename: Christine
authors.initials: C
authors.lastname: Mian
authors.forename: Roman
authors.initials: R
authors.lastname: Mayr
authors.forename: Evi
authors.initials: E
authors.lastname: Comploj
authors.forename: Emanuela
authors.initials: E
authors.lastname: Trenti
authors.forename: Roberto
authors.initials: R
authors.lastname: Melotti
authors.forename: Fabio
authors.initials: F
authors.lastname: Campodonico
authors.forename: Massimo
authors.initials: M
authors.lastname: Maffezzini
authors.forename: Hans-Martin
authors.initials: HM
authors.lastname: Fritsche
authors.forename: Armin
authors.initials: A
authors.lastname: Pycha
mesh_terms: D000782:Aneuploidy; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology*; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000235:genetics* / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000473:pathology*